Hyeong-Jin Kim , Seung-Woo Yu , Kee-Tae Kim , Dong-Uk Ahn , Na-Kyoung Lee , Hyun-Dong Paik
{"title":"Neuroprotective effects of pepsin-hydrolyzed ovotransferrin on H2O2-induced oxidative damage in SH-SY5Y neuronal cells","authors":"Hyeong-Jin Kim , Seung-Woo Yu , Kee-Tae Kim , Dong-Uk Ahn , Na-Kyoung Lee , Hyun-Dong Paik","doi":"10.1016/j.bioorg.2026.109613","DOIUrl":null,"url":null,"abstract":"<div><div>Neurodegenerative diseases are considered critical disorders due to the absence of effective treatments and serious damage to brain function. Ovotransferrin, an egg white protein, and its hydrolysate obtained using proteolytic enzymes have been reported to have beneficial effects on various bioactive functions. Therefore, the purpose of this study was to investigate the neuroprotective effects of enzymatically hydrolyzed ovotransferrin in SH-SY5Y cells exposed to oxidative stress. Hydrolyzed ovotransferrin showed higher antioxidative activities than pure ovotransferrin. Furthermore, 0.5 mg/mL of pepsin-derived ovotransferrin hydrolysate (OHPE) exhibited the highest cell viability (81.89%), and OHPE effectively reduced cellular ROS accumulation (72%) and decreased total apoptosis rate (46.41%). These anti-apoptotic and antioxidative effects were influenced by the regulation of the mRNA and protein expression of Bax, Bcl-2, caspase-9, caspase-3, Nrf2, and HO-1. Additionally, nine peptides comprising OHPE were identified by LC-MS/MS and compared with the sequences reported in DFBP to explore their potential as antioxidants. These results indicate that OHPE can be used as a nature-derived compound to prevent neurodegenerative diseases by inhibiting ROS interactions and regulating protein expression in neuronal cells.</div></div>","PeriodicalId":257,"journal":{"name":"Bioorganic Chemistry","volume":"173 ","pages":"Article 109613"},"PeriodicalIF":4.7000,"publicationDate":"2026-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic Chemistry","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0045206826001495","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/6 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Neurodegenerative diseases are considered critical disorders due to the absence of effective treatments and serious damage to brain function. Ovotransferrin, an egg white protein, and its hydrolysate obtained using proteolytic enzymes have been reported to have beneficial effects on various bioactive functions. Therefore, the purpose of this study was to investigate the neuroprotective effects of enzymatically hydrolyzed ovotransferrin in SH-SY5Y cells exposed to oxidative stress. Hydrolyzed ovotransferrin showed higher antioxidative activities than pure ovotransferrin. Furthermore, 0.5 mg/mL of pepsin-derived ovotransferrin hydrolysate (OHPE) exhibited the highest cell viability (81.89%), and OHPE effectively reduced cellular ROS accumulation (72%) and decreased total apoptosis rate (46.41%). These anti-apoptotic and antioxidative effects were influenced by the regulation of the mRNA and protein expression of Bax, Bcl-2, caspase-9, caspase-3, Nrf2, and HO-1. Additionally, nine peptides comprising OHPE were identified by LC-MS/MS and compared with the sequences reported in DFBP to explore their potential as antioxidants. These results indicate that OHPE can be used as a nature-derived compound to prevent neurodegenerative diseases by inhibiting ROS interactions and regulating protein expression in neuronal cells.
期刊介绍:
Bioorganic Chemistry publishes research that addresses biological questions at the molecular level, using organic chemistry and principles of physical organic chemistry. The scope of the journal covers a range of topics at the organic chemistry-biology interface, including: enzyme catalysis, biotransformation and enzyme inhibition; nucleic acids chemistry; medicinal chemistry; natural product chemistry, natural product synthesis and natural product biosynthesis; antimicrobial agents; lipid and peptide chemistry; biophysical chemistry; biological probes; bio-orthogonal chemistry and biomimetic chemistry.
For manuscripts dealing with synthetic bioactive compounds, the Journal requires that the molecular target of the compounds described must be known, and must be demonstrated experimentally in the manuscript. For studies involving natural products, if the molecular target is unknown, some data beyond simple cell-based toxicity studies to provide insight into the mechanism of action is required. Studies supported by molecular docking are welcome, but must be supported by experimental data. The Journal does not consider manuscripts that are purely theoretical or computational in nature.
The Journal publishes regular articles, short communications and reviews. Reviews are normally invited by Editors or Editorial Board members. Authors of unsolicited reviews should first contact an Editor or Editorial Board member to determine whether the proposed article is within the scope of the Journal.